Gilead Sciences hits a 52-week high buoyed by investor optimism. We believe there is still room for growth and recommend the ...

The injection, known as Lenacapavir, works by preventing the virus from multiplying within body cells and could provide protection for an entire year. Researchers noted that the injection differs from ...

The table is a review of notable updates that occurred in February 2025 for investigational products in development.